Rednovember24
Posted - 1 week ago
@MRTunity @Profitfire I’m also thinking a drop will happen to shake out more weaklings before the news. Sometime I’ll tell y’all about $MYOV. I see a similar replay of history here.
Bigprofits23
Posted - 2 weeks ago
$MYOV Awww to bad for Sumi after screwing the MYOV stock holders. Corruption has Karma!
https://www.fiercepharma.com/pharma/sumitomo-pharma-lays-another-400-us-staffers-face-sliding-revenues
sempiternal1
Posted - 3 weeks ago
$ARDX A double indication drug with large TAMs is pretty unusual. It’s even more unusual for it to still be owned by a small pharma. Maximum value for buyouts are generally at <12 months from last approval. I think this company has a better shot than most to get one in the next 6 months. Similar to $MYOV $ALBO. Also, X excitement will drive sp into earnings I imagine.
Overall, I would love to see the bundling issue completely removed (75% chance per RJ report) but dialysis is a margin thin business. My guess is the new hire was brought in to negotiate around this issue and pitch on value as if bundling won’t happen. It’s better to let this ticker go at $16-$20 then let the full picture come into view. You start to run into patent life questions, length of full revenue, DCF gets smaller, etc. Sell big pharma on the dream now and let them fight out the details
GL to all.
Bigprofits23
Posted - 3 weeks ago
@newandimproveddonkeykong Sooo TRUE! I was in MYOV for 4 years! Yikes. Road from 8 to 31 back to 7’s, then BO at $27.
I knew what I owned even though lowball BO because they had a majority stock holder. Was also in PRVB with the money from MYOV.
In at 7 out at BO of $25. $ARDX seems like a much easier hold and buy than $MYOV or $PRVB. GL!
NobVega
Posted - 1 month ago
$ARQT I said $IMGN and $MYOV would be bought out. I'm saying the same here. I'm only holding 8k shares, but expect a $20 buyout from here.
Lets_Go_Brndn
Posted - 1 month ago
$BTTX Frank talks Tuesday. Listen to what a successful CEO has to say. And don’t forget his involvement in $MYOV. Frank doesn’t know anything but success. “Media” pop-up writes come and go like diarrhea in a diaper. Very similar
west281356
Posted - 2 months ago
@airplaneb747 @R408 reminds me of the $MYOV Take under at $27….
Quad_
Posted - 2 months ago
@stelzer $IMMU and $MYOV were, too.
Bigprofits23
Posted - 3 months ago
@Bamabeast256 If there was evidence it would be illegal, right?
I have been involved in 2 BO’s over the last 15 months. $MYOV & $PRVB ARDX seems to have the best management team out of the 3. That would be the only reason I would say NA to a BO unless it was relatively high. But as I SPECULATE the previous BO’s were $27 & $25 respectively. GL!
RTuckr
Posted - 3 months ago
@Governor_Richie @Elvira007 @Governor_Richie @Elvira007 there would be an announcement saying… MREO has agreed to be bought by XYZ @$9.00. The buyout takes time(2-6months) but in the short term, before the deal finalizes, it would trade at $8.xx - gets closer to 9 the more imminent the date is. Any shares you still own by the acquisition date will turn to cash.
See $MYOV.
fin_researcher
Posted - 4 months ago
$MYOV Myovant Sciences was acquired by Sumitovant of Sumitomo Pharma for $27.00 per share in cash via a merger transaction. Based on J.P. Morgan's valuations for $MYOV, Sumitovant was willing to pay $29.50 per share in a competitive bidding scenario. Investors suspect that they were misled in voting for a merger at a price that was less than Myovant’s full and fair value. https://11thestate.com/cases/myovant-mna-lawsuit
nosoul777
Posted - 11/30/23
$IMGN gosh, I love it when I'm right! Number 5 for me in the past year-ish. $MYOV, $PRVB, $SPPI, $ALBO and now $IMGN. I wish I had more money in here right now, but I'll take a win wherever I get it these days. 🙂
fin_researcher
Posted - 11/27/23
$MYOV Myovant Sciences was acquired by Sumitovant of Sumitomo Pharma for $27.00 per share in cash via a merger transaction. Based on J.P. Morgan's valuations for $MYOV, Sumitovant was willing to pay $29.50 per share in a competitive bidding scenario. Investors suspect that they were misled in voting for a merger at a price that was less than Myovant’s full and fair value. To claim compensation: https://11thestate.com/cases/myovant-mna-lawsuit
Quad_
Posted - 5 months ago
$AUPH It’s always important to remember there will be wolves in sheep’s clothing on StockTwits. Happened in $MYOV with my beloved friend Fade. To this day, I’m pretty sure Fade was Myrtle’s bitch. Some knowledge, fancy charts, and then some FUD. Some of that is happening here, too. This will get bought. Just be careful who you listen to here. Chances are you’re talking to some mid level hedge fund guy that just got over a bender and has to protect his firms short position… or accumulate.
mrmark47299
Posted - 10/31/23
$TTOO I did this for 2 year's with $MYOV
GOT BOUGHT OUT, AND THEN I THREW IT ALL AWAY WITH $TTOO. (BUT I AINT SELLING)!
mrmark47299
Posted - 10/31/23
@momneedsnewshoes I did this for 2 year's with $MYOV
GOT BOUGHT OUT, AND THEN I THREW IT ALL AWAY WITH $TTOO. (BUT I AINT SELLING)!
Auphiliate
Posted - 10/26/23
@Goodfriend98 @Valleycapital @TonyK666 Learned my lesson here. Best to go with biotechs with better sales potential. $TGTX and most recently $MYOV for me! Lupkynis is a good product but smaller patient population and too easy for greedy management to stuff their pockets then hide behind a million excuses. Yes, there are many other similar biotechs. I will avoid them as well. 🧐
fin_researcher
Posted - 6 months ago
Investors who faced losses from the $MYOV stock dip may have a chance for recovery. https://11thestate.com/cases/myovant-mna-lawsuit
jnc1631
Posted - 6 months ago
@Bobes almost thought you were talking about Dave Marek from $MYOV. I still have flashbacks to that brutal experience. Maybe Daves are bad luck
stockilluminati
Posted - 6 months ago
$MYOV https://clinicaltrials.gov/study/NCT05862272 - trial update posted here!
Quad_
Posted - 6 months ago
$AUPH You know you're about to get bought out when the company stops doing PR's. Patent news and the news below is evidence of that. Crickets from management. This is exactly what happened with $MYOV. Sure hope Tony is OK and didn't get Carlosed.
stockilluminati
Posted - 6 months ago
$MYOV https://www.stockilluminati.com/myov/news.php - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
fin_researcher
Posted - 6 months ago
$MYOV
shoddy
Posted - 6 months ago
@Buckeye80 Same happened when I was looking to buy $MYOV it dropped and was the perfect time to buy yet wanted to hold this junk longer and missed that BO also $TRIL another quick turnaround from a decline to BO. Let’s hope this is the end here for AUP
nosoul777
Posted - 6 months ago
$AUPH long time lurker, first time posting. I've been involved in 4 BOs in the past 12mo ($MYOV, $ALBO, $SPPI, and $PRVB) and this stock follows none of them. Sure, there's an occasional comparison that can be made, but this is in a league of its own as far as the crazy goes. I never really realized how much the CEO mattered. Now I know, and I will pay much closer attention to this in future investments.
TrendyChart
Posted - 6 months ago
Upcoming Earnings Report: $MYOV Myovant Sciences will be reporting on 10/25/2023 at 8:00AM What's your take on the earnings potential of this stock?
cctranscripts
Posted - 09/29/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV https://conferencecalltranscripts.com/summary/?id=528537&pr=true $MYOV
stockilluminati
Posted - 09/29/23
$MYOV https://www.stockilluminati.com/myov/news.php - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV